Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal

Recruiting Observational Study
Heart Disease Congenital Neurodevelopmental Disorder
Ready to participate?

Review the details below, then apply to join this clinical trial.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Congenital heart defects (CHD), as the leading cause of birth defects, affect 12 million people globally and approximately 41,000 newborns each year in Europe. CHD presents a significant public health concern due to its association with high morbidity and mortality rates across the lifespan. Over 50% of infants born with critical CHD will develop neurodevelopmental disorders (NDD), requiring speci…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
The inclusion criteria are as follows: * Fetus with a congenital heart defect (CHD) detected prenatally (prenatal diagnosis of the heart defect) * Fetus with a critical CHD defined as requiring cardiac surgery during the first three months of the infant's life * Parents affiliated with or beneficia…
Contacts

Alban Baruteau

+33 2 40 08 77 42

albanelouen.baruteau@chu-nantes.fr

CONTACT